Neuromuscular Disorders
Volume 20, Issue 2 , Pages 111-121 , February 2010

Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation

  • Joseph J. Belanto

      Affiliations

    • Dept. of Urology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA
    • Dept. of Human Genetics, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA
    • ,
  • Silvia V. Diaz-Perez

      Affiliations

    • Dept. of Human Genetics, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA
    • ,
  • Clara E. Magyar

      Affiliations

    • Translational Pathology Core Laboratory, Dept. of Pathology and Laboratory Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA
    • ,
  • Michele M. Maxwell

      Affiliations

    • MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA
    • ,
  • Yasemin Yilmaz

      Affiliations

    • Dept. of Urology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA
    • ,
  • Kasey Topp

      Affiliations

    • Dept. of Human Genetics, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA
    • ,
  • Guney Boso

      Affiliations

    • Dept. of Human Genetics, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA
    • ,
  • Catriona H. Jamieson

      Affiliations

    • Dept. of Medicine, Hematology/Oncology Division, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA
    • ,
  • Nicholas A. Cacalano

      Affiliations

    • Dept. of Radiation Oncology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA
    • ,
  • Christina A.M. Jamieson

      Affiliations

    • Dept. of Urology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA
    • Dept. of Human Genetics, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, USA
    • Corresponding Author InformationCorresponding author. Address: Dept. of Urology, David Geffen School of Medicine at UCLA, 4554 Gonda Center-708822, 695 Charles E. Young Dr. S., Los Angeles, CA 90095, USA. Tel.: +1 310 267 2469; fax: +1 310 794 5446.

Received 10 July 2009 ,Revised 30 November 2009 ,Accepted 3 December 2009.

References 

  1. Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet. 1998;20:31–36
  2. Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet. 1998;20:37–42
  3. Illa I, Serrano-Munuera C, Gallardo E, Lasa A, Rojas-García R, Palmer J, et al. Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol. 2001;49:130–134
  4. Fanin A, Angelini C. Muscle pathology in dysferlin deficiency. Neuropathol Appl Neurobiol. 2002;28:461–470
  5. Klinge L, Aboumousa A, Eagle M, Hudson J, Sarkozy A, Vita G, et al. New aspects on patients affected by dysferlin deficient muscular dystrophy. J Neurol Neurosurg Psychiatry. 2009;[Epub ahead of print]
  6. Gallardo E, Rojas-Garcia R, De Luna N, Pou A, Brown RH, Illa I. Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology. 2001;57:2136–2138
  7. Hoffman EP, Rao D, Pachman LM. Clarifying the boundaries between the inflammatory and dystrophic myopathies: insights from molecular diagnostics and microarrays. Rheum Dis Clin North Am. 2002;28:743–757
  8. Confalonieri P, Oliva L, Andreetta F, Lorenzoni R, Dassi P, Mariani E, et al. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study. J Neuroimmunol. 2003;142:130–136
  9. Prelle A, Sciacco M, Tancredi L, Fagiolari G, Comi GP, Ciscato P, et al. Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency. Acta Neuropathol (Berl). 2003;105:537–542
  10. Selva-O’Callaghan A, Labrador-Horrillo M, Gallardo E, Herruzo A, Grau-Junyent JM, Vilardell-Tarres M. Muscle inflammation, autoimmune Addison’s disease and sarcoidosis in a patient with dysferlin deficiency. Neuromuscul Disord. 2006;16:208–209
  11. Nguyen K, Bassez G, Krahn M, Bernard R, Laforêt P, Labelle V, et al. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch Neurol. 2007;64:1176–1182
  12. Paradas C, González-Quereda L, De Luna N, Gallardo E, García-Consuegra I, Gómez H, et al. A new phenotype of dysferlinopathy with congenital onset. Neuromuscul Disord. 2009;19:21–25
  13. Anderson LV, Davison K, Moss JA, Young C, Cullen MJ, Walsh J, et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet. 1999;8:855–861[Erratum in: Hum Mol Genet 1999;8:1141]
  14. Matsuda C, Hayashi YK, Ogawa M, Aoki M, Murayama K, Nishino I, et al. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet. 2001;10:1761–1766
  15. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature. 2003;423:168–172
  16. Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem. 2003;278:50466–50473
  17. De Luna N, Gallardo E, Soriano M, Dominguez-Perles R, de la Torre C, Rojas-Garcia R, et al. Absence of dysferlin alters myogenin expression and delays human muscle differentiation “in vitro”. J Biol Chem. 2006;281:17092–17098
  18. Glover L, Brown RH. Dysferlin in membrane trafficking and patch repair. Traffic. 2007;8:785–794
  19. Doherty KR, Cave A, Davis DB, Delmonte AJ, Posey A, Earley JU, et al. Normal myoblast fusion requires myoferlin. Development. 2005;132:5565–5575
  20. Klinge L, Laval S, Keers S, Haldane F, Straub V, Barresi R, et al. From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis. FASEB J. 2007;21:1768–1776
  21. Chiu YH, Hornsey MA, Klinge L, Jørgensen LH, Laval SH, Charlton R, et al. Attenuated muscle regeneration is a key factor in dysferlin deficient muscular dystrophy. Hum Mol Genet. 2009;18:1976–1989
  22. Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2008;1:CD003725
  23. Angelini C. The role of corticosteroids in muscular dystrophy: a critical appraisal. Muscle Nerve. 2007;36:424–435
  24. Anderson JE, Weber M, Vargas C. Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy. Cell Transplant. 2000;9:551–564
  25. Golumbek PT, Keeling RM, Connolly AM. Strength and corticosteroid responsiveness of mdx mice is unchanged by RAG2 gene knockout. Neuromuscul Disord. 2007;17:376–384
  26. Rogatsky I, Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq CM, et al. Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc Natl Acad Sci USA. 2003;100:13845–13850
  27. Jamieson CA, Yamamoto KR. Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling. Proc Natl Acad Sci USA. 2000;97:7319–7324
  28. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 1998;12:3343–3356
  29. Carballo-Jane E, Pandit S, Santoro JC, Freund C, Luell S, Harris G, et al. Skeletal muscle: a dual system to measure glucocorticoid-dependent transactivation and transrepression of gene regulation. J Steroid Biochem Mol Biol. 2004;88:191–201
  30. Harridge SD. Plasticity of human skeletal muscle: gene expression to in vivo function. Exp Physiol. 2007;92:783–797
  31. tePas MF, de Jong PR, Verburg FJ. Glucocorticoid inhibition of C2C12 proliferation rate and differentiation capacity in relation to mRNA levels of the MRF gene family. Mol Biol Rep. 2000;27:87–98
  32. Sun L, Trausch-Azar JS, Muglia LJ, Schwartz AL. Glucocorticoids differentially regulate degradation of MyoD and Id1 by N-terminal ubiquitination to promote muscle protein catabolism. Proc Natl Acad Sci USA. 2008;105:3339–3344
  33. Semsarian C, Wu MJ, Ju YK, Marciniec T, Yeoh T, Allen DG, et al. Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway. Nature. 1999;400:576–581
  34. Sultan KR, Henkel B, Terlou M, Haagsman HP. Quantification of hormone-induced atrophy of large myotubes from C2C12 and L6 cells: atrophy-inducible and atrophy-resistant C2C12 myotubes. Am J Physiol Cell Physiol. 2006;290:C650–C659
  35. Maxwell MM, Brown RH, manuscript in preparation.
  36. Nofziger D, Miyamoto A, Lyons KM, Weinmaster G. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development. 1999;126:1689–1702
  37. Ratajczak MZ, Kucia M, Reca R, Majka M, Janowska-Wieczorek A, Ratajczak J. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells ‘hide out’ in the bone marrow. Leukemia. 2004;18:29–40
  38. Nervina JM, Magyar CE, Pirih FQ, Tetradis S. PGC-1alpha is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts. Bone. 2006;39:1018–1025
  39. Mamo S, Gal AB, Bodo S, Dinnyes A. Quantitative evaluation and selection of reference genes in mouse oocytes and embryos cultured in vivo and in vitro. BMC Dev Biol. 2007;7:14
  40. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034.1-0034.12
  41. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101–1108
  42. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25:402–408
  43. Carlson CG, Samadi A, Siegel A. Chronic treatment with agents that stabilize cytosolic IkappaB-alpha enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch. Neurobiol Dis. 2005;20:719–730
  44. Diaz-Perez SV, Ferguson DO, Wang C, Csankovszki G, Wang C, Tsai SC, et al. A deletion at the mouse Xist gene exposes trans-effects that alter the heterochromatin of the inactive X chromosome and the replication time and DNA stability of both X chromosomes. Genetics. 2006;174:1115–1133
  45. Miura P, Andrews M, Holcik M, Jasmin BJ. IRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells. PLoS ONE. 2008;3:e2309
  46. Britton S, Freeman T, Vafiadaki E, Keers S, Harrison R, Bushby K, et al. The third human FER-1-like protein is highly similar to dysferlin. Genomics. 2000;68:313–321
  47. Fisher I, Abraham D, Bouri K, Hoffman EP, Muntoni F, Morgan J. Prednisolone-induced changes in dystrophic skeletal muscle. FASEB J. 2005;19:834–836Erratum in: FASEB J 2005 May;19(7):1 p following 836. Hoffmann, Eric P [corrected to Hoffman, Eric P]
  48. Almon RR, Yang E, Lai W, Androulakis IP, Ghimbovschi S, Hoffman EP, et al. Relationships between circadian rhythms and modulation of gene expression by glucocorticoids in skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2008;295:R1031–R1047
  49. Peter AK, Ko CY, Kim MH, Hsu N, Ouchi N, Rhie S, et al. Myogenic Akt signaling upregulates the utrophin–glycoprotein complex and promotes sarcolemma stability in muscular dystrophy. Hum Mol Genet. 2009;18:318–327
  50. Inoue M, Wakayama Y, Kojima H, Shibuya S, Jimi T, Oniki H, et al. Expression of myoferlin in skeletal muscles of patients with dysferlinopathy. Tohoku J Exp Med. 2006;209:109–116
  51. Brack AS, Conboy IM, Conboy MJ, Shen J, Rando TA. A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell. 2008;2:50–59
  52. Lo HP, Cooper ST, Evesson FJ, Seto JT, Chiotis M, Tay V, et al. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis. Neuromuscul Disord. 2008;18:34–44
  53. Kramerova I, Kudryashova E, Wu B, Spencer MJ. Regulation of the M-cadherin-beta-catenin complex by calpain 3 during terminal stages of myogenic differentiation. Mol Cell Biol. 2006;26:8437–8447
  54. Foxton RM, Laval SH, Bushby KM. Characterisation of the dysferlin skeletal muscle promoter. Eur J Hum Genet. 2004;12:127–131
  55. Armand AS, Bourajjaj M, Martínez-Martínez S, el Azzouzi H, da Costa Martins PA, Hatzis P, et al. Cooperative synergy between NFAT and MyoD regulates myogenin expression and myogenesis. J Biol Chem. 2008;283:29004–29010
  56. Belanto JJ, Jamieson CAM, manuscript in preparation.
  57. O’Connor RS, Mills ST, Jones KA, Ho SN, Pavlath GKA. Combinatorial role for NFAT5 in both myoblast migration and differentiation during skeletal muscle myogenesis. J Cell Sci. 2007;120:149–159
  58. Szustakowski JD, Lee JH, Marrese CA, Kosinski PA, Nirmala NR, Kemp DM. Identification of novel pathway regulation during myogenic differentiation. Genomics. 2006;87:129–138
  59. Parsons SA, Millay DP, Sargent MA, Naya FJ, McNally EM, Sweeney HL, et al. Genetic disruption of calcineurin improves skeletal muscle pathology and cardiac disease in a mouse model of limb-girdle muscular dystrophy. J Biol Chem. 2007;282:10068–10078
  60. Cerletti M, Jurga S, Witczak CA, Hirshman MF, Shadrach JL, Goodyear LJ, et al. Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell. 2008;134:37–47

PII: S0960-8966(09)00700-7

doi: 10.1016/j.nmd.2009.12.003

Neuromuscular Disorders
Volume 20, Issue 2 , Pages 111-121 , February 2010

Article Tools

* Image Usage & Resolution